Clinical Trial Update: Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study of Adapalene Gel 0.3% in subjects with facial acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Adapalene Gel 0.3% (adapalene)

Snippet

Sponsor: Aleor Dermaceuticals Limited | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED